Active Ingredient(s): Telbivudine
FDA Approved: * October 25, 2006
Pharm Company: * IDENIX PHARMA
Category: Hepatitis

Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (European Union) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance.[1][2][3] However, HBV signature resistance mutation M204I (a change from methionine to isoleucine at positi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tyzeka LDT
Tyzeka 600 mg Oral Tablet
NDC: 0078-0538
Novartis Pharmaceuticals Corporation
Tyzeka 20 mg/ml Oral Solution
NDC: 0078-0539
Novartis Pharmaceuticals Corporation